BRCA1 and BRCA2: From molecular genetics to clinical medicine

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1969-1977

  Blackwood, M Anne ^a   Weber, Barbara L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BREAST CANCER; CANCER THERAPY; CHROMOSOME 17Q; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; GENE MUTATION; GENOME; MOLECULAR GENETICS; PRIORITY JOURNAL;

EID: 0031832736     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1969     Document Type: Article

References (64)

1. Williams WR, Andersen DE: Genetic epidemiology of breast incer: Segregation and analysis of 200 Danish pedigrees. Genet Didemiol 1: 7,1984
2. Newman B, Austin MA, Lee M, et al.: Inheritance of breast cancer: vidence for autosomal dominant transmission in high-risk families. soc Natl Acad Science USA 85: 3044,1988
3. Miki Y, Swensen J, Shattuck-Eidens D, et al.: A strong candidate r the breast and ovarian cancer susceptibility gene BRCA1. Science i6: 66,1994
4. Wooster R, Bignell G, Lancaster J, et al.: Identification of the sast cancer susceptibility gene BRCA2. Nature 378: 789,1995
5. Tavtigian SV, Simard J, Romens J, et al.: The BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet 12: 333-337,1996
6. Hall JM, Lee MK, Newman B, et al.: Linkage of early-onset breast cancer to chromosome 17q21. Science 250: 1684-1689,1990
7. Narod SA, Feuteun J, Lynch H, et al.: Familial breast-ovarian cancer locus on chromosome 17q21-21. Lancet 338: 82-83,1991
8. Easton DF, Bishop DT, Ford D, et al.: Genetic linkage analysis in familial breast and ovarian cancer-Results from 214 families. Am J Hum Genet 52: 678-701, 1993
9. Wooster R, Neuhausen S, Mangion J, et al.: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13ql2-13. Science 265: 2088-2090,1994
10. Serova OM, Mazoyer S, Puget N, et al.: Mutations in BRCAl and BRCA2 in breast cancer families: Are there more breast cancersusceptibility genes? Am J Human Genet 60: 486-495 1997
11. Shattuck-Eidens D, Oliphant A, McClure M, et al.: BRCAl sequence analysis in women at high risk for susceptibility mutations. JAMA278: 1242-1250,1997
12. Couch FJ, DeShano M, Blackwood MA, et al.: BRCAl mutations in women attending clinics that evaluate the risk of breast cancer. New EnglJMed 336: 1409-1415,1997
13. Berry DA, Parmigiani G, Sanchez J, et al.: Probability of carrying a mutation of breast-ovarian cancer gene BRCAl based on family history. J Natl Cancer Inst, 89: 227-238,1997
14. Easton DF, Bishop DT, Ford D, et al.: Breast and ovarian cancer incidence in BRCAl mutation carriers. Am J Hum Genet 56: 267-271, 1995
15. Ford D, Easton DF, Bishop DT, et al.: Risk of cancer in BRCAl mutation carriers. Lancet 343: 692-695,1994
16. Streuwing JP, Hartge P, Wacholder S, et al.: Cancer risk with ISSdelAG and 5382insC mutations of BRCAl and the 6174delT mutation of BRCA2 among Ashkenazi Jews. New Engl J Med 336: 1401-1408, 1997
17. Marcus JN, Watson P, Page DL, et al.: Hereditary breast cancer: Pathobiology, prognosis, and BRCAl and BRCA2 gene linkage. Cancer 77: 697-709,1996
18. Rubin SC, Benjamin I, Behbakht K, et al.: Clinical and pathological features of ovarian cancer in women with germline mutations of BRCAl. N Engl J Med 19: 1413-1416,1996
19. Lakahani SR, Sloane JP, Gusterson BA, et al.: The pathology of familial breast cancer: Evidence for differences between breast cancers developing in carriers of BRCAl mutations, BRCA2 mutations, and sporadic cases. Lancet (in press)
20. Eisinger F, Stoppa-Lyonnet D, Longy M, et al.: Germline mutation at BRCAl affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56: 471,1996
21. Lindblom A, Skoog L, Rotstein S,et al.: Loss of heterozygosity in familial breast carcinoma. Cancer Res 53: 4356-4361,1993
22. Thompson ME, Jensen RA, Obermiller DS, et al.: Decreased expression of BRCAl accelerates growth and is often present during cancer progression. Nature Genet 9: 444-450,1995
23. Holt JT, Thompson ME, Szabo C, et al.: Growth retardation and tumour inhibition by BRCAl. Nature Genet 12: 298-302,1996
24. Gudas JM, Nguyen H, Li T, et al.: Hormone-dependent regulation of BRCAl in human breast cancer cells. Cancer Res 55: 4561-4565, 1995
25. Gudas JM, Li T,-Nguyen H, et al.: Cell cycle regulation of BRCAl messenger RNA in human breast epithelial cells. Cell Growth Diff 7: 717-723,1996
26. Vaughn JP, Davis PL. Jarboe MD, et al.: BRCAl expression is induced before DNA synthesis in both normal and tumor derived breast cells. Cell Growth Diff 7: 711-715,1996
27. Chen Y, Farmer AA, Jones DC, et al.: BRCAI is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56: 3168-3172,1996
28. Scully R, Chen J, Plug A, et al.: Association of BROA1 ndRadSl in mitotic and meiotic cells. Cell 88: 265-275,1997
29. Chapman MS, Verma IM: Transcriptional activation by BRCAl. Nature 382: 678-679,1997
30. Thakur S, Zhang HB, Peng Y, et al.: Localization of BRCAl and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17: 444-452,1997
31. Milner J, Ponder B, Hughes-Davies L, et al.: Transcriptional activation functions in BRCA2. Nature 386: 772-773,1997
32. Sharan SK, Morimatsu M, Albrecht U, et al.: Emb'ryonic lethality and radiation hypersensitivity mediated by RadSl in mice lacking BRCA2. Nature 386: 804-810,1997
33. Chen Y, Chen CF, Riley DJ, et al.: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791,1995
34. Scully R, Ganesan S, Brown M, et al.: Localization of BRCA1 in human breast and ovarian cancer cells. Science 272: 123-126,1996
35. Jensen RA, Thompson ME, Jetton TL, et al.: BRCA1 is secreted and exhibits properties of a granin. Nature Genet 12: 303-308,1996
36. Wilson CA, Payton MN, Pekar SK, et al.: BRCAl protein products: Antibody specificity. Nature Genet 13: 264-265,1996
37. Wilson CA, Payton MN, Elliott GS, et al.: Differential subcellular localization and biological toxicity of BRCAl and the splice variant BRCAl-DUb, Oncogene 14: 1-16,1997
38. Marquis ST, Rajan JV, Wynshaw-Boris A, et al.: The developmental pattern of BRCAl expression and modulation by ovarian hormones implies a role in differentiation of the breast and other tissues. Nature Genet 11: 17-26,1995
39. Boyd M, Harris R, Mcfarlane H, et al.: A human BRCAl gene knockout. Nature 375: 541-542,1995
40. Gayther SA, Warren W, Mazoyer S, et al.: Germline mutations of the BRCAl gene in breast/ovarian cancer families provide evidence for a genotype/phenotype correlation. Nature Genet 11: 428-433,1995
41. Sobol H, Stoppa-Lyonnet D, Bressac-de-Paillerets B, et al.: Truncation at conserved terminal regions of BRCAl protein is associated with highly proliferating hereditary breast cancers. Cancer Res 56: 3126-3129,1996
42. Matsushima M, Kobayashi K, Emi M, et al.: Mutation analysis of the BRCAl gene in 76 Japanese ovarian cancer patients: Four germline mutations, but no evidence of somatic mutation. Hum Molec Genet 4: 1953-1956,1995
43. Merajver SD, Pham TM, Caduff RF, et al.: Somatic mutations in the BRCAl gene in sporadic ovarian tumors. Nature Genet 9: 439-443, 1995
44. Hosking L, Trowsdale J, Nicolai H et al.: A somatic BRCAl mutation in an ovarian rumor. Nature Genet 9: 343-344,1995
45. Takahashi H, Behbakht K, McGovern PE, et al.: Mutation analysis of the BRCAl gene in ovarian cancers. Cancer Res 55: 2998-3002,1995
46. Couch FJ, Fand LM, DeShano ML, et al.: BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet 13: 123-125,1996
47. Neuhausen S, Gilewski T, Norton LJ, et al.: Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genet 13: 126-128,1996
48. Phelan CM, Lancaster JM, Tonin P, et al.: Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet 13: 120-122,1996
49. Lancaster JM, Wooster R, Mangion J, et al.: BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13: 238-240,1996
50. Miki Y, Katagiri T, Kasumi F, et al.: Mutation analysis on the BRCA2 gene in primary breast cancers. Nature Genet 13: 245-247,1996
51. Teng DHF, Bogden R, Mitchell J, et al.: Low incidence of BRCA2 in breast carcinoma and other cancers. Nature Genet 13: 241-244,1996
52. Takahashi H, Chiu HC, Bandera CA, et al.: Mutations of the BRCAl gene in ovarian carcinomas. Cancer Res 56: 2738-2741,1996
53. Tonin P, Serova O, Lenoir G, et al.: BRCA1 mutations in Ashkenazi Jewish women. Am J Human Genet 57: 189,1995
54. Streu wing JP, Abeliovich D, Peterz T, et al.: The carrier frequency of the BRCAI 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 11: 198-200,1995
55. Roa BB, Boyd AA, Volcik K, et al.: Ashkenazi Jewish population frequency for common mutations in BRCAI and BRCA2. Nature Genet 14: 185-190,1996
56. Tonin P, Weber B, Offit K, et al.: Frequency of recurrent BRCAI and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Med 2: 1179-1183, 1996
57. Abeliovich D, Kaduri L, Lerer I, et al.: The founder mutations 185delAG and 5382insC in BRCAI and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Human Genet 60: 505-514,1997
58. Neuhausen SL, Mazoyer S, Friedman L, et al.: Haplotype and phenotype analysis of six recurrent BRCAI mutations in 61 families: Results of an international study. Am J Hum Genet 58: 271-280,1996
59. Berman DB, Wagner-Costalas J, Schultz DC, et a. : Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: A genetic study of 15 1 SSdelAG mutation kindreds. Am J Hum Genet 58: 1166-1176,1996
60. Gayther SA, Harrington P, Russell P, et al.: Rapid detection of regionally clustered germline BRCAJ mutations by multiplex heteroduplex analysis. Am J Hum Genet 58: 451-456,1996
61. Castilla LH, Couch FJ, Erdos MR, et al.: Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet 8: 387-391,1994
62. Friedman LS, Ostermeyer EA, Szabo CI, et al.: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8: 399-404,1994
63. Hogervorst FBL, Cornelis RS, Bout M, et al.: Rapid detection of BRCAl mutations by the protein truncation test. Nature Genet 10: 208-212,1995
64. Plummer SJ, Anton-Culver H, Webster L, et al.: Detection of BRCAl mutations by the protein truncation test. Hum Mol Genet 4: 1989-1991,1995